Publications by authors named "M B Kirkpatrick"

Ecology and evolution are considered distinct processes that interact on contemporary time scales in microbiomes. Here, to observe these processes in a natural system, we collected a two-decade, 471-metagenome time series from Lake Mendota (Wisconsin, USA). We assembled 2,855 species-representative genomes and found that genomic change was common and frequent.

View Article and Find Full Text PDF

Background: Although studies have compared on-treatment effectiveness of infliximab and vedolizumab in patients with ulcerative colitis (UC), there has been limited comparison of treatment sequencing and long-term patient-centred outcomes.

Aim: To compare infliximab-first and vedolizumab-first strategy in biologic-naïve patients with UC.

Methods: We conducted a retrospective cohort study in biologic-naïve patients with UC who were treated first with either infliximab or vedolizumab between 2015 and 2021 and followed over 30 months following initiation.

View Article and Find Full Text PDF

Background: Depression in pregnancy can increase vulnerability for psychiatric disorders in the offspring, likely via the transfer of heightened maternal cortisol and cytokines to the in-utero environment. However, the precise cellular and molecular mechanisms, are largely unclear. Animal studies can represent this complex pathophysiology at a systemic level but are expensive and ethically challenging.

View Article and Find Full Text PDF

Background: Instructors used generative artificial intelligence (AI) as a teaching tool in a third-year baccalaureate nursing leadership course to help students understand and critique a change management proposal.

Method: Instructors used generative AI to develop a sample section of a change proposal for students to critique in class followed by a class discussion.

Results: Using generative AI enabled instructors to quickly develop a sample section of a change proposal for students to critique.

View Article and Find Full Text PDF

Background: Understanding public opinions about emerging tobacco products is important to inform future interventions and regulatory decisions. Heated tobacco products (HTPs) are an emerging tobacco product category promoted by the tobacco industry as a "better alternative" to combustible cigarettes. Philip Morris International's IQOS is leading the global HTP market and recently has been subject to important policy events, including the US Food and Drug Administration's (FDA) modified-risk tobacco product (MRTP) authorization (July 2020) and the US import ban (November 2021).

View Article and Find Full Text PDF